Asiatic Laboratories Limited (DSE:ASIATICLAB)

Market Cap	7.64B +66.0%
Revenue (ttm)	2.24B +52.2%
Net Income	378.08M +40.8%
EPS	3.09 +1.0%
Shares Out	122.39M
PE Ratio	20.20
Forward PE	n/a
Dividend	1.00 (1.66%)
Ex-Dividend Date	Nov 23, 2025

Volume	1,769,045
Average Volume	2,435,211
Open	60.00
Previous Close	60.30
Day's Range	59.30 - 64.30
52-Week Range	29.00 - 73.00
Beta	1.04
RSI	50.76
Earnings Date	Feb 4, 2026

About Asiatic Laboratories

Asiatic Laboratories Limited manufactures and sells pharmaceutical products in Bangladesh and internationally. The company offers tablets, capsules, oral liquids, powder for suspension, ophthalmic, injectable, and others product. It distributes its products through sales distribution centers and a store. The company also exports its products. Asiatic Laboratories Limited was incorporated in 1970 and is headquartered in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 1970
• Employees: 737
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ASIATICLAB

Financial Performance

In fiscal year 2025, Asiatic Laboratories's revenue was 1.77 billion, an increase of 27.45% compared to the previous year's 1.39 billion. Earnings were 255.36 million, a decrease of -8.30%.